by the end of the fifth follow-up year , the examined patients from group 1 showed a reduction in the mean level of total cholesterol and hypercholesterolemia rates , following by a decrease in total and cardiovascular mortality by 6.5 and 5.7 % , respectively , the incidence of myocardial infarction and stroke and the risk of death from these complications becoming lower .
C0007226
cardiovascular
C0038454
stroke